| Delmar Gardens South | |
| 5300 Butler Hill Road, Saint Louis, Missouri 63128 | |
| (314) 842-0588 | |
| Name | Delmar Gardens South |
|---|---|
| Location | 5300 Butler Hill Road, Saint Louis, Missouri |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 149 |
| Occupancy Rate | 85.23% |
| Medicare ID (CCN) | 265310 |
| Legal Business Name | Delmar Gardens Of South County, Inc. |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1659366516 |
| Organization Name | DELMAR GARDENS OF SOUTH COUNTY, INC. |
| Doing Business As | DELMAR GARDENS SOUTH |
| Address | 5300 Butler Hill Rd, Saint Louis, MO 63128 |
| Phone Number | 314-842-0588 |
News Archive
The BMJ and Channel 4 Dispatches investigated and found that evidence suggesting potential harm from the drugs in industry studies has not been published.
Barr Pharmaceuticals, Inc. has announced that U.S. District Court for Delaware has ruled in favor of its subsidiary, Barr Laboratories, Inc., in the challenge of the patent listed by Boehringer Ingelheim Pharmaceuticals, Inc. in connection with Boehringer Ingelheim's Mirapex(R) Tablets (pramipexole dihydrochloride) 0.125mg, 0.25mg, 0.5mg, 1mg & 1.5mg.
The final results of a six-month, multi-center, open-label Phase 3 study of VIAject® (more-rapid-acting injectable human insulin) versus regular human insulin (RHI) in 471 patients with type 2 diabetes were presented today by Helena Rodbard, M.D., at the 70th Scientific Sessions of the American Diabetes Association. Dr. Rodbard was a principal investigator of this study, which was designed to evaluate the safety and efficacy of VIAject® versus regular human insulin when used in combination with insulin glargine.
McClatchy/The Sacramento Bee reports on a the experience of Scott Hawkins, a 23-year old student who received five minutes of ER care at the UC Davis Medical Center before being pronounced dead. McClatchy reports: "Few question the extent to which doctors tried to save the student's life on Oct. 21, but the amount billed for his emergency care has provoked outrage - a further example, critics said, of what is wrong in a health care system that is roundly maligned for its escalating costs."
› Verified 7 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
The BMJ and Channel 4 Dispatches investigated and found that evidence suggesting potential harm from the drugs in industry studies has not been published.
Barr Pharmaceuticals, Inc. has announced that U.S. District Court for Delaware has ruled in favor of its subsidiary, Barr Laboratories, Inc., in the challenge of the patent listed by Boehringer Ingelheim Pharmaceuticals, Inc. in connection with Boehringer Ingelheim's Mirapex(R) Tablets (pramipexole dihydrochloride) 0.125mg, 0.25mg, 0.5mg, 1mg & 1.5mg.
The final results of a six-month, multi-center, open-label Phase 3 study of VIAject® (more-rapid-acting injectable human insulin) versus regular human insulin (RHI) in 471 patients with type 2 diabetes were presented today by Helena Rodbard, M.D., at the 70th Scientific Sessions of the American Diabetes Association. Dr. Rodbard was a principal investigator of this study, which was designed to evaluate the safety and efficacy of VIAject® versus regular human insulin when used in combination with insulin glargine.
McClatchy/The Sacramento Bee reports on a the experience of Scott Hawkins, a 23-year old student who received five minutes of ER care at the UC Davis Medical Center before being pronounced dead. McClatchy reports: "Few question the extent to which doctors tried to save the student's life on Oct. 21, but the amount billed for his emergency care has provoked outrage - a further example, critics said, of what is wrong in a health care system that is roundly maligned for its escalating costs."
› Verified 7 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 13.28 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 2.92 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 29.75 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.52 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 5.22 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 1.15 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 4.23 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 78.62 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 22.15 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 93.69 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.1 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 9.96 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 25.32 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 3.02 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 90.02 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 65.38 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 80.62 | 82.93 |
News Archive
The BMJ and Channel 4 Dispatches investigated and found that evidence suggesting potential harm from the drugs in industry studies has not been published.
Barr Pharmaceuticals, Inc. has announced that U.S. District Court for Delaware has ruled in favor of its subsidiary, Barr Laboratories, Inc., in the challenge of the patent listed by Boehringer Ingelheim Pharmaceuticals, Inc. in connection with Boehringer Ingelheim's Mirapex(R) Tablets (pramipexole dihydrochloride) 0.125mg, 0.25mg, 0.5mg, 1mg & 1.5mg.
The final results of a six-month, multi-center, open-label Phase 3 study of VIAject® (more-rapid-acting injectable human insulin) versus regular human insulin (RHI) in 471 patients with type 2 diabetes were presented today by Helena Rodbard, M.D., at the 70th Scientific Sessions of the American Diabetes Association. Dr. Rodbard was a principal investigator of this study, which was designed to evaluate the safety and efficacy of VIAject® versus regular human insulin when used in combination with insulin glargine.
McClatchy/The Sacramento Bee reports on a the experience of Scott Hawkins, a 23-year old student who received five minutes of ER care at the UC Davis Medical Center before being pronounced dead. McClatchy reports: "Few question the extent to which doctors tried to save the student's life on Oct. 21, but the amount billed for his emergency care has provoked outrage - a further example, critics said, of what is wrong in a health care system that is roundly maligned for its escalating costs."
› Verified 7 days ago
Friendship Village Sunset Hills Location: 12651 Village Circle Drive, Saint Louis, Missouri 63127 Phone: (314) 270-7777 | |
Christian Extended Care & Rehabilitation Location: 11160 Village North Drive, Saint Louis, Missouri 63136 Phone: (314) 355-8010 | |
Delmar Gardens South Location: 5300 Butler Hill Road, Saint Louis, Missouri 63128 Phone: (314) 842-0588 | |
Chestnut Rehab And Nursing Location: 10954 Kennerly Road, Saint Louis, Missouri 63128 Phone: (314) 843-4242 | |
Royal Oak Nursing & Rehab Location: 4960 Laclede Avenue, Saint Louis, Missouri 63108 Phone: (314) 361-6240 |